D. E. Shaw & Co., Inc. Insmed Inc Transaction History
D. E. Shaw & Co., Inc.
- $122 Billion
- Q4 2024
A detailed history of D. E. Shaw & Co., Inc. transactions in Insmed Inc stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 10,000 shares of INSM stock, worth $775,000. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000
Previous 66,735
85.02%
Holding current value
$775,000
Previous $4.87 Million
85.83%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding INSM
# of Institutions
497Shares Held
189MCall Options Held
3.21MPut Options Held
2.72M-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.41 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY14.3MShares$1.11 Billion0.02% of portfolio
-
Darwin Global Management, Ltd. St. Helier, Y913MShares$1 Billion84.75% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD12.7MShares$985 Million0.1% of portfolio
-
Capital International Investors Los Angeles, CA7.12MShares$552 Million0.1% of portfolio
About INSMED Inc
- Ticker INSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,476,992
- Market Cap $10.5B
- Description
- Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...